DocGo Inc. (NASDAQ:DCGO) Receives Average Recommendation of “Hold” from Analysts

by · The Markets Daily

Shares of DocGo Inc. (NASDAQ:DCGO – Get Free Report) have received an average recommendation of “Hold” from the six brokerages that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $2.38.

DCGO has been the topic of several recent analyst reports. Canaccord Genuity Group reiterated a “hold” rating and issued a $1.00 price target on shares of DocGo in a report on Tuesday, August 18th. Needham & Company LLC restated a “buy” rating on shares of DocGo in a report on Wednesday. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DocGo in a research report on Monday, September 14th.

Read Our Latest Research Report on DocGo

DocGo Price Performance

DocGo stock opened at $0.37 on Friday. DocGo has a 1-year low of $0.31 and a 1-year high of $1.65. The firm has a market capitalization of $36.55 million, a P/E ratio of -0.19 and a beta of 0.97. The company’s 50-day moving average is $0.47 and its 200 day moving average is $0.56.

DocGo (NASDAQ:DCGO – Get Free Report) last announced its quarterly earnings data on Monday, August 17th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.06). DocGo had a negative return on equity of 40.42% and a negative net margin of 65.29%.The firm had revenue of $73.42 million during the quarter, compared to the consensus estimate of $75.35 million. Research analysts anticipate that DocGo will post -0.22 earnings per share for the current fiscal year.

Institutional Trading of DocGo

A number of large investors have recently made changes to their positions in DCGO. Renaissance Technologies LLC grew its holdings in shares of DocGo by 167.1% in the first quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock worth $950,000 after purchasing an additional 944,826 shares during the last quarter. S Squared Technology LLC bought a new stake in DocGo during the 2nd quarter valued at about $1,060,725. BlackRock Inc. bought a new stake in DocGo during the 2nd quarter valued at about $750,000. Isthmus Partners LLC lifted its holdings in DocGo by 14.0% during the 1st quarter. Isthmus Partners LLC now owns 1,013,056 shares of the company’s stock valued at $637,000 after buying an additional 124,211 shares in the last quarter. Finally, GSA Capital Partners LLP purchased a new stake in DocGo in the 2nd quarter valued at about $517,000. 56.44% of the stock is owned by hedge funds and other institutional investors.

About DocGo

(Get Free Report)

DocGo Inc (NASDAQ: DCGO) is a healthcare services and technology company that delivers medical care and transportation outside traditional clinical settings. Its platform combines mobile clinical services, technology-enabled care coordination and non-emergency medical transportation to help healthcare providers, government agencies, insurers and employers serve patients in their homes and communities.

The company’s services include ambulance and non-emergency medical transportation, mobile primary and urgent care, remote patient monitoring, diagnostic testing, vaccination programs and community-based healthcare.

Featured Stories